Clinical Trials Browser

Phase 3 × Tegafur × Head & Neck × Clear all

NCT02363400 2025-08-19

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

Phase 3 Terminated

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT00336947 2013-05-15

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Phase 3 Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms